| 2022 | Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients
| JOURNAL OF MOLECULAR DIAGNOSTICS |
| 2021 | 다발골수종 및 관련 형질세포 질환의 조기 진단을 위한 선별 검사
| Korean Journal of Medicine |
| 2021 | 국내 임상시험 및 대상자 보호프로그램 도입 현황과 안전관리체계에 대한 설문조사 연구
| Journal of Korean association of IRB |
| 2021 | Risk factors for neutropenic fever in non-Hodgkin's lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2021 | Clinical characteristics and prognostic factors of acquired haemophilia A in Korea | HAEMOPHILIA |
| 2021 | Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma | CLINICAL CANCER RESEARCH |
| 2021 | Updated recommendations for the treatment of venous thromboembolism
| BLOOD RESEARCH |
| 2021 | Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients
| JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION |
| 2021 | Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
| EXPERIMENTAL HEMATOLOGY & ONCOLOGY |
| 2021 | Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2021 | Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma | SUPPORTIVE CARE IN CANCER |
| 2021 | Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2020 | Human herpesvirus 8-negative effusion-based lymphoma with indolent clinical behavior in an elderly patient: A case report and literature review
| ONCOLOGY LETTERS |
| 2020 | Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
| BLOOD CANCER JOURNAL |
| 2020 | Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis | LEUKEMIA & LYMPHOMA |
| 2020 | Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome | THROMBOSIS RESEARCH |
| 2020 | Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database
| CANCER RESEARCH AND TREATMENT |
| 2020 | Immunosuppressive role of CD11b + CD33 + HLA-DR - myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia
| CANCER MEDICINE |
| 2020 | Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma | ANNALS OF HEMATOLOGY |
| 2020 | First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
| CANCERS |
| 2020 | Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partners | PATIENT EDUCATION AND COUNSELING |
| 2020 | Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL) | BONE MARROW TRANSPLANTATION |
| 2020 | Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era
| SCIENTIFIC REPORTS |
| 2020 | Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study | INTERNATIONAL JOURNAL OF HEMATOLOGY |
| 2020 | Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease | ANNALS OF HEMATOLOGY |
| 2020 | ULK1 Inhibition as a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
| 2020 | Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial
| CANCER RESEARCH AND TREATMENT |
| 2020 | PERK/NRF2 and Autophagy Form a Resistance Mechanism Against G9a Inhibition in Leukemia Stem Cells
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
| 2020 | The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria | BLOOD |
| 2019 | Clinical Implication of Renal Dysfunction During the Clinical Course in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Longitudinal Analysis | ANNALS OF HEMATOLOGY |
| 2019 | 후천성 혈우병 A
| Clinical and Experimental Thrombosis and Hemostasis |
| 2019 | 국소적 대상포진이 발생한 면역저하환자로부터 유발된 수두의 발생
| Korean Journal of Nosocomial Infection Control (병원감염관리) |
| 2019 | Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/-DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| 2019 | Induction of apoptosis and differentiation by Na/H exchanger 1 modulation in acute myeloid leukemia cells | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2019 | A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| 2019 | Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization | Japanese Journal of Clinical Oncology |
| 2018 | Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
| 2018 | HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
| CANCER RESEARCH AND TREATMENT |
| 2018 | A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System | BRITISH JOURNAL OF HAEMATOLOGY |
| 2017 | Comprehensive Evaluation of the Revised International Staging System in Multiple Myeloma Patients Treated with Novel Agents as a Primary Therapy | AMERICAN JOURNAL OF HEMATOLOGY |
| 2017 | Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial. | LANCET HAEMATOLOGY |
| 2017 | Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study. | LEUKEMIA |
| 2017 | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
| ONCOTARGET |
| 2017 | Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
| ONCOTARGET |
| 2017 | Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma | HEMATOLOGICAL ONCOLOGY |
| 2017 | Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma
| ONCOTARGET |
| 2017 | The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)
| ONCOTARGET |
| 2017 | Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial
| BLOOD RESEARCH |
| 2017 | Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma
| ONCOTARGET |
| 2017 | Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort
| BLOOD RESEARCH |
http://orcid.org/0000-0001-8986-8436
(55032033600)
